vimarsana.com

இலிஂக்‌வர்த் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Illingworth Research Group wins prestigious Queen s Award

Illingworth Research Group wins ‘prestigious’ Queen’s Award Company recognised with a 2021 Queen’s Award for Enterprise for International Trade Syneos Health company Illingworth Research Group has been recognised with a 2021 Queen’s Award for Enterprise for International Trade, making it one of 205 UK-based organisations to win this award.  Illingworth Research Group provides clinical research home health services, employing over 200 people across the world. The company, which was established in 1998, was acquired then by Syneos last December. “We are all incredibly proud to be honoured with this prestigious award for our sustained achievements and consistent growth,” said John Illingworth, chairman, Illingworth Research Group.

Finding the right partners key to decentralized trials

A leader from the mobile research nursing specialist offers advice on what to look for in a service provider, and why finding the right one is vital. With COVID-19 causing a surge in decentralized trials, pharmaceutical firms and their research teams increasingly are looking to qualified technology and service providers to help bring the studies to the patients, in their homes. Gerard Barron, vice president of operations for Illingworth Research Group, a Syneos Health Company, spoke with Outsourcing-Pharma about how to choose qualified providers, and why joining forces with the right company can make a significant difference. OSP: Could you please share your perspective on how decentralized trial (DCT) technology has evolved in recent years?​

Illingworth Research Group Recognized with Queen s Award for Enterprise: International Trade 2021

Illingworth Research Group Recognized with Queen’s Award for Enterprise: International Trade 2021 MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) The Illingworth Research Group, a Syneos Health ® company, has been recognized with a 2021 Queen’s Award for Enterprise for International Trade. Illingworth Research Group™ is a leading global provider of clinical research home health services. With healthcare already becoming more local, COVID-19 has accelerated the need for in-home clinical trial services which have realized increasing demand in recent years. Illingworth is one of only 205 UK-based organizations to be recognized with the prestigious Queen’s Award. With this acknowledgement, Illingworth Research becomes the first organization to be awarded the highly acclaimed industry SCRIP Award as Best Specialist Provider, and a Queens Award for Enterprise: International Trade, in the same year.  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.